May 3, 2018 / 1:31 AM / 10 months ago

Judge sets swift schedule for assessing Aegerion victim claims

A federal magistrate judge on Wednesday said she wanted to move swiftly in assessing claims by victims seeking a cut of a U.S. Justice Department settlement with Aegerion Pharmaceuticals Inc over its improper marketing of a cholesterol drug.

U.S. Magistrate Judge Marianne Bowler at a hearing in Boston sought to assess the best path to distributing up to $7.2 million set aside for patients who were harmed after using Juxtapid, a drug produced by Aegerion, a Novelion Therapeutics Inc unit.

To read the full story on Westlaw Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below